New study on the secondary prevention of myocardial infarct using oral anticoagulants
de Jonge, F.A.; Jonker, J.J.
Nederlands Tijdschrift Voor Geneeskunde 127(31): 1391-1394
1983
ISSN/ISBN: 0028-2162 PMID: 6621724 Document Number: 217944
Document emailed within 1 workday
Related Documents
Di Pasquale, G.; Ottani, F.; Ceré, E.; Biancoli, S.; Sassone, B.; Lombardi, A. 1998: Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct Recenti Progressi in Medicina 89(10): 514-519Schilling, J.; Schwendinger, M.; Vranjes, N.; Gutzwiller, F. 1996: Thrombolysis following myocardial infarct. European Secondary Prevention Study Praxis 85(42): 1311-1315
van de Loo, J.; Kienast, J. 1992: Platelet inhibitors or anticoagulants in prevention after myocardial infarct? The 1991 state of the art Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(1): 1-5
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Filipecki, S.; Hajduk, B.; Vertun-Baranowska, B. 1994: Secondary prevention by using oral anticoagulants in patients with clinically acute massive pulmonary embolism Pneumonologia i Alergologia Polska 62(3-4): 150-153
Follath, F. 1986: Secondary prevention following myocardial infarct Schweizerische Rundschau für Medizin Praxis 75(40): 1177-1180
Bocková, E.; Polácková, J. 1985: Behavior pattern in the secondary prevention of myocardial infarct Ceskoslovenska Psychiatrie 81(2): 96-99
Paragh, G.; Balogh, Z.; Boda, J.; Mohácsi, A.; Kovács, P.; Polgár, P.; Wórum, F.; Kakuk, G. 1997: Lipid lowering treatment in secondary prevention following myocardial infarct Orvosi Hetilap 138(29): 1849-1853
Einecke, D. 2011: Secondary prevention. Pills without co-pay reduce complications after myocardial infarct MMW Fortschritte der Medizin 153(48): 15
Bungeroth, K.A. 1987: Secondary prevention following myocardial infarct. Which drug treatment is safe today? Fortschritte der Medizin 105(31): 607-611
Asperger, Z.; Jursic, M. 1970: Prolonged administration of anticoagulants after myocardial infarct Lijecnicki Vjesnik 92(3): 369-374
Schweizer, W. 1979: Long-term administration of anticoagulants following myocardial infarct Deutsche Medizinische Wochenschrift 104(6): 208
Oberemchenko, I.V.; Atamanchuk, N.S.; Bel'skiĭ, N.E. 1975: Changes in the coagulation and anticoagulation systems of blood in myocardial infarct during the process of treatment with anticoagulants and fibrinolysin Vrachebnoe Delo 1975(11): 21-26
Nightingale, A.; Marshall, A. 1998: Secondary prevention in acute myocardial infarction. Long term insulin treatment is important in secondary prevention in diabetic patients Bmj 317(7166): 1153
Sárosi, I.; Debreceni, G.; Mühl, D.; Kónyi, A.; Bogár, L.; Tekeres, M.; Tóth, K.; Habon, T.; Czopf, L.; Zámbó, K.; Schmidt, E. 1997: Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction Orvosi Hetilap 138(31): 1939-1945
Petrov, V.I.; Shatalova, O.V.; Maslakov, A.S.; Shatalov, A.A. 2014: The place of novel oral anticoagulants in prevention and treatment of venous thromboembolism Angiologiia i Sosudistaia Khirurgiia 20(3): 89-93
Stoupel, E. 1982: Stress, causative factor of or secondary reaction to myocardial infarct Revue Medicale de Liege 37(Suppl 1): 25-28
Diener, H.C.; Weiller, C. 1993: Ticlopidine. Secondary prevention of ischemic cerebral infarct Der Internist 34(12): 1150-1155
Baudet, M.; Maisonneuve, D.; Normand, J.P.; Boschat, J.; Mathivat, A. 1978: Myocardial infarct and oral contraceptives Annales de Medecine Interne 129(6-7): 459-462
Bounhoure, J.P.; Marco, J.; Fauvel, J.M.; Gassia, J.; Cassainc, J.; Delsol, S.; Calazel, P. 1977: Oral contraceptives and myocardial infarct Archives des Maladies du Coeur et des Vaisseaux 70(7): 765-771